Shares of Makino were untraded Friday, while Nidec’s stock jumped more than 5%. The offer aligns with Nidec’s strategy to expand into higher-margin growth sectors as it faces challenges such as ...
Objective: To evaluate the efficacy and safety of tacrolimus in interstitial pneumonia with autoimmune features (IPAF). Methods: 48 IPAF patients receiving tacrolimus were retrospectively analyzed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback